• 1
    Melton L 1993 Hip fractures: A worldwide problem today and tomorrow Bone 14:S1S8.
  • 2
    Lips P, van Ginkel FC, Jongen MJ, Rubertus F, van der Vijgh WJ, Netelenbos JC 1987 Determinants of vitamin D status in patients with hip fracture and in elderly control subjects Am J Clin Nutr 46:10051010.
  • 3
    Cooper C, McLaren M, Wood P, Coulton L, Kanis J 1989 Indices of calcium metabolism in women with hip fractures Bone Miner 5:193200.
  • 4
    Benhamou CL, Tourliere D, Gauvain JB, Picaper G, Audran M, Jallet P 1995 Calciotropic hormones in elderly people with and without hip fracture Osteoporos Int 5:103107.
  • 5
    Boonen S, Broos P, Verbeke G, Aerssen J, Van Herck E, Jans I, Dequeker J, Bouillon R 1997 Calciotropic hormones and markers of bone remodeling in age-related (type I) femoral neck osteoporosis: Alterations consistent with secondary hyperparathyroidism-induced bone resorption J Gerontol 52:M286M293.
  • 6
    Prestwood K, Panaullo A, Kenny A, Pilbeam C, Raisz L 1996 The effect of a short course of calcium and vitamin-D on bone turnover in older women Osteoporos Int 6:314319.
  • 7
    Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ 1992 Vitamin D3 and calcium to prevent hip fractures in elderly women N Engl J Med 327:16371642.
  • 8
    Riggs B, Melton L 1983 Evidence for two distinct syndromes of involutional osteoporosis Am J Med 75:899901.
  • 9
    Raisz L 1990 Local and systemic factors in the pathogenesis of osteoporosis N Engl J Med 318:818828.
  • 10
    Lips P, Courpron P, Meunier PJ 1978 Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age Calcif Tissue Res 10:1317.
  • 11
    Parfitt A, Mathews C, Villanueva A, Kleerekoper M, France B, Rao D 1983 Relationships between surface, and thickness of iliac trabecular bone in aging and in osteoporosis J Clin Invest 72:13961409.
  • 12
    Arlot M, Edouard C, Meunier PJ, Neer RM, Reeve J 1984 Impaired osteoblast function in osteoporosis: Comparison between calcium balance and dynamic histomorphometry Br Med J 289:517520.
  • 13
    Stauffer M, Baylink DJ, Wergedal JE, Rich C 1973 Decreased bone formation, mineralization and enhanced resorption in calcium-deficient rats Am J Physiol 225:269276.
  • 14
    Tanimoto H, Lau K-HW, Nishimoto SK, Wergedal JE, Baylink DJ 1991 Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model Calcif Tissue Int 48:101110.
  • 15
    Boonen S, Lesaffre E, Dequeker J, Aerssens J, Pelemans W, Bouillon R 1996 Relationship between baseline insulin-like growth factor-I and femoral bone density in women aged over 70 years: Potential implications for the prevention of age-related bone loss J Am Geriatr Soc 44:13011306.
  • 16
    Mohan S, Farley JR, Baylink DJ 1995 Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging Growth Factor Res 6:465473.
  • 17
    Mohan S, Baylink DJ 1991 Bone growth factors Clin Orthop 263:3048.
  • 18
    Hayden JM, Mohan S, Baylink DJ 1995 The insulin-like growth factor system and the coupling of formation to resorption Bone 17:93S98S.
  • 19
    Wergedal JE, Mohan S, Lundy M, Baylink DJ 1990 Skeletal growth factors and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells J Bone Miner Res 5:179186.
  • 20
    Ebeling P, Jones J, O'Fallon W, Janess C, Riggs B 1993 Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women J Clin Endocrinol Metab 77:13841387.
  • 21
    Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R 1995 Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women J Bone Miner Res 10:18441852.
  • 22
    Guler HP, Zapf J, Schmid C, Froesch ER 1989 Insulin-like growth factors I and II in healthy man: Estimations of half-lives and production rates Acta Endocrinol (Copenh) 121:753758.
  • 23
    Guler HP, Zapf E, Scheiwiller E, Froesch ER 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats Proc Natl Acad Sci USA 85:48894893.
  • 24
    Zapf J, Hauri C, Waldvogel M, Futo E, Hasler H, Binz K, Guler HP, Schmid C, Froesch ER 1989 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats Proc Natl Acad Sci USA 86:38133817.
  • 25
    Knauer DJ, Smith GL 1980 Inhibition of biologic activity of multiplication-stimulating activity by binding to its carrier protein Proc Natl Acad Sci USA 77:72527256.
  • 26
    Elgin RG, Busby WH, Clemmons DR 1987 An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF I Proc Natl Acad Sci USA 84:32543258.
  • 27
    Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3 Endocrinology 127:807814.
  • 28
    Bautista CM, Baylink DJ, Mohan S 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone Biochem Biophys Res Commun 176:756763.
  • 29
    Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells J Biol Chem 35:2042420431.
  • 30
    Delmas P 1990 Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease Endocrinol Metab Clin North Am 1:118.
  • 31
    Boonen S, Lesaffre E, Aerssens J, Pelemans W, Dequeker J, Bouillon R 1996 Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alteration in body composition Gerontology 42:330338.
  • 32
    Cockroft D, Gault M 1976 Prediction of creatinine clearance from serum creatinine Nephron 16:3141.
  • 33
    Bouillon R, Van Kerkhove P, De Moor P 1976 Measurement of 25-hydroxyvitamin D3 in serum Clin Chem 22:364368.
  • 34
    Bouillon R, Coopmans W, Degroote DE, Radoux D, Eliard PH 1990 Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies Clin Chem 36:271276.
  • 35
    Bouillon R, Vanderschueren D, Van Herck E, Nielsen HK, Bex M, Heyns W, Van Baelen H 1992 Homologous radioimmunoassay of human osteocalcin Clin Chem 38:20552060.
  • 36
    Farley JR, Chestnut CH, Baylink DJ 1981 Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin Clin Chem 27:20022007.
  • 37
    Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J 1996 Immunoassay for intact amino-terminal propeptide of human type-I procollagen Clin Chem 42:947954.
  • 38
    Vanderschueren D, Jans I, Van Herck E, Bouillon R 1994 Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats Bone Miner 26:123131.
  • 39
    Mohan S, Baylink DJ 1995 Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C18 Sep-Pak separation J Clin Endocrinol Metab 80:637647.
  • 40
    Mohan S, Libanati CR, Dony C, Lang K, Srinivasan N, Baylink DJ 1995 Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids J Clin Endocrinol Metab 80:26382645.
  • 41
    Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S 1996 Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids J Clin Endocrinol Metab 81:13891396.
  • 42
    Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM 1995 Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women J Bone Miner Res 10:11771184.
  • 43
    Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD 1982 Vitamin D. and bone health in the elderly Am J Clin Nutr 36:10141031.
  • 44
    Akesson K, Vergnaud P, Gineyts E, Delmas PD, Obrant KJ 1993 Impairment of bone turnover in elderly women with hip fracture Calcif Tissue Int 53:162169.
  • 45
    Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ 1992 The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures J Clin Endocrinol Metab 74:2427.
  • 46
    Young GA, Hill GL 1978 Assessment of protein-calorie malnutrition in surgical patients from plasma proteins and anthropometric measurements Am J Clin Nutr 31:429435.
  • 47
    Older MW, Edward D, Dickerson JW 1980 A. nutrient survey in elderly women with femoral neck fractures Br J Surg 67:884886.
  • 48
    Isley WL, Underwood LE, Clemmons DR 1983 Dietary components that regulate serum somatomedin-C in humans J Clin Invest 71:175182.
  • 49
    Isley WL, Underwood LE, Clemmons DR 1984 Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content J Parenter Enter Nutr 8:407411.
  • 50
    Clemmons DR, Underwood LE 1991 Nutritional regulation of IGF-I and IGF binding proetins Annu Rev Nutr 11:393412.